UroGen Pharma (URGN) Payables (2016 - 2026)
UroGen Pharma's Payables came in at $39.95 million for Q2 2026, up 29.0% from $30.96 million a year earlier and up 13.0% from the prior quarter.
Analysis
UroGen Pharma (URGN) Payables (2016 - 2026) Analysis & Trends
At the end of FY2025, UroGen Pharma's Payables was $27.72 million, up 1.0% from FY2024.
- Payables has increased in each of the last five years, with a five-year compound annual growth rate of 22.6% (FY2020 to FY2025).
- Going back by year, Payables was $27.43 million in FY2024 (+65.9%), $16.54 million in FY2023 (+33.6%), $12.38 million in FY2022 (+2.3%) and $12.1 million in FY2021 (+20.7%).
- The Q2 2026 figure represents the highest quarterly Payables in data going back to Q4 2016.
- Year-over-year, Payables has increased for 15 consecutive quarters, with growth averaging 35.3% over the last eight quarters.
- The fastest year-over-year change in Payables over five years came in Q2 2023 (growth of 89.7%), and the weakest in Q2 2022 (a decline of 16.4%).
- Business Quant data shows URGN's Payables at $35.35 million (Q1 2026), $27.72 million (Q4 2025) and $26.17 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,138.83 Bn | 1,107.41 Bn | 19.71 Bn | 6.11 Bn |
| 2 | Johnson & Johnson | 618.88 Bn | 537.41 Bn | 17.26 Bn | 20.92 Bn |
| 3 | AbbVie | 502.93 Bn | 476.04 Bn | 12.70 Bn | 33.30 Bn |
| 4 | Merck | 369.61 Bn | 323.99 Bn | 12.21 Bn | 5.96 Bn |
| 5 | Novartis Ag | 298.70 Bn | 262.69 Bn | 11.24 Bn | 4.26 Bn |
| 6 | Astrazeneca | 261.35 Bn | 235.03 Bn | 12.86 Bn | 22.89 Bn |
| 7 | Amgen | 237.59 Bn | 192.99 Bn | 7.24 Bn | 2.87 Bn |
| 8 | Gilead Sciences | 191.60 Bn | 165.79 Bn | 6.22 Bn | 674.00 Mn |
| 9 | Pfizer | 170.23 Bn | 116.88 Bn | 10.94 Bn | 7.03 Bn |
| 10 | UroGen Pharma | 1.80 Bn | 1.30 Bn | 65.88 Mn | 39.95 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 39.95 Mn |
| Mar 31, 2026 | 35.35 Mn |
| Dec 31, 2025 | 27.72 Mn |
| Sep 30, 2025 | 26.17 Mn |
| Jun 30, 2025 | 30.96 Mn |
| Mar 31, 2025 | 30.32 Mn |
| Dec 31, 2024 | 27.43 Mn |
| Sep 30, 2024 | 19.69 Mn |
| Jun 30, 2024 | 23.75 Mn |
| Mar 31, 2024 | 18.16 Mn |
| Dec 31, 2023 | 16.54 Mn |
| Sep 30, 2023 | 14.08 Mn |
| Jun 30, 2023 | 16.40 Mn |
| Mar 31, 2023 | 17.13 Mn |
| Dec 31, 2022 | 12.38 Mn |
| Sep 30, 2022 | 9.36 Mn |
| Jun 30, 2022 | 8.65 Mn |
| Mar 31, 2022 | 9.94 Mn |
| Dec 31, 2021 | 12.10 Mn |
| Sep 30, 2021 | 11.06 Mn |
API Access
UroGen Pharma Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=payables&ticker=URGN&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "payables", "ticker": "URGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=payables&ticker=URGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();